Philippines

Mercury Drug Corporation

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 29.95 Industry: Pharmacies and Drug Stores Available in: English Format: PDF Download Most recent financial data: 2015 Buy full report

What’s included?

This report extracts all available information about Mercury Drug Corporation from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Headquarters
#7 Mercury Avenue Cor E Rodriguez Jr Bagumbayan, Quezon City
Quezon City; National Capital Region; Map
Postal Code: 1110

Tel: (02) 911-

Company Description
Mercury Drug Corporation operates a network of company-owned and franchised drugstores. The company retails drugs and other pharmaceutical goods and products in the Philippines. The company was established in 1945 and has its office located in Quezon City.
NAICS Industry Classification
Main Activities: Pharmacies and Drug Stores
Basic Information
Financial Auditors:
()
Profile Updated:
June 20, 2017
Key Financial Highlights
2015 Y
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 36,295,637
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Individual
Source: CIBI Information Inc, EMIS Company Database.
Financial Performance Charts
Top Competitors

Financial Statements

Annual Statements

EMIS Credit Analytics

EMIS Benchmark Score

Latest News (Not included in the report)

Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

REQUEST A DEMO

To view more information, REQUEST A DEMO